ECNP Congress, 15th-18th October - Vienna, Austria

The annual ECNP Congress is Europe’s premier scientific meeting for disease-oriented brain research, annually attracting more than 5,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world. Transpharmation will be presenting two posters; (1) Differential effects of repeated treatment with DOI and psilocybin on the head-twitch response (HTR), locomotor activity and anxiety-like behaviour and (2) 2,5-Dimethoxy-4-iodoamphetamine (DOI) enhances motivation in low and medium but not high performers in the progressive ratio (PR) task in rats. We look forward to seeing you, but if you are unable to attend this event, we will make the posters available to you on our publications page after October 18th. For more details, please feel free to contact us.